Evidence map›Paper›PMID 32581535›Full record

ArticleInternational journal of nanomedicine2020

Nanoparticle-Based Vaccines for Brucellosis: Calcium Phosphate Nanoparticles-Adsorbed Antigens Induce Cross Protective Response in Mice.

Zohre Sadeghi, Mahdi Fasihi-Ramandi, Saeid Bouzari

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Topical review on nano-vaccinology: Biochemical promises and key challenges.Process biochemistry (Barking, London, England) · 2021
    Review
  11. Applications of Nanovaccines for Disease Prevention in Cattle.Frontiers in bioengineering and biotechnology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Zohre SadeghiDepartment of Molecular Biology, Pasteur Institute of Iran, Tehran, Iran.
Mahdi Fasihi-RamandiMolecular Biology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Saeid BouzariDepartment of Molecular Biology, Pasteur Institute of Iran, Tehran, Iran.
Pasteur Institute of Iran · IRBaqiyatallah University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionVaccine formulation with appropriate adjuvants is an attractive approach to develop protective immunity against pathogens. Calcium phosphate nanoparticles (CaPNs) are considered as ideal adjuvants and delivery systems because of their great potential for enhancing immune responses. In the current study, we have designed nanoparticle-based vaccine candidates to induce immune responses and protection against MATERIALS AND

methodsFor this purpose, we used three

resultsThe CaPNs showed an average size of about 90 nm with spherical shape and smooth surface. The CaPNs-adsorbed proteins displayed significant increase in cellular and humoral immune responses compared to the control groups. In addition, our results showed increased ratio of specific IgG2a (associated with Th1) to specific IgG1 (associated with Th2). Also, immunized mice with different vaccine candidate formulations were protected against DISCUSSION: Our data support the hypothesis that these antigens absorbed with CaPNs could be effective vaccine candidates against

Indexed as

Adjuvants, ImmunologicAnimalsAntigens, BacterialBacterial ProteinsBrucella abortusBrucella melitensisBrucella VaccineBrucellosisCalcium PhosphatesDrug Delivery SystemsFemaleImmunity, HumoralImmunizationImmunoglobulin GMembrane Transport ProteinsMice, Inbred BALB CAdjuvants, ImmunologicAntigens, BacterialBacterial ProteinsBhuA protein, Brucella abortusBrucella Vaccinecalcium phosphateCalcium PhosphatesImmunoglobulin GMembrane Transport ProteinsadjuvantBrucellacalcium phosphate nanoparticleimmune responsevaccine

Identifiers

PMID32581535
PMCPMC7269176
OpenAlexW3031126606

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.